-

Outlook on the Worldwide Telemedicine Industry to 2027 - by Component, Delivery Model, Technology, Application, Type, End Use, Region and Segment Forecasts - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Telemedicine Market Size, Share & Trends Analysis Report by Component, by Delivery Model, by Technology, by Application (Teleradiology, Telepsychiatry), by Type, by End Use, by Region, and Segment Forecasts, 2020 - 2027" report has been added to ResearchAndMarkets.com's offering.

The global telemedicine market size is expected to reach USD 155.1 billion by 2027, expanding at a CAGR of 15.1% over the forecast period. Increasing incidences of chronic conditions and rising demand for self-care medicines are the key factors driving the market. Furthermore, increasing use of internet applications, ease of telemedicine, and rising demand for centralization of healthcare are expected to help save cost, which is one of the critical factors for the telemedicine market growth.

The healthcare industry is enormously huge and its centralization is expected to help in harmonizing the entire process as well as providing economic assistances. The unprecedented outbreak of COVID-19 across the globe has resulted into increased demand for telemedicine solutions, due to lockdown implemented by several countries as a preventive measure to curb the pandemic.

Moreover, owing to their capability to monitor various chronic conditions such as diabetes, cardiovascular conditions, and cancer, telemedicine solutions are expected to experience substantial development in the coming years. The growing prevalence of cardiac conditions, increase in geriatric population, and the constant demand for self-governing by patients are the high impact rendering drivers of this industry.

Telemedicine is helping in reducing the emergency room visits and hospitalization rate, thereby augmenting the market growth. Moreover, improving therapeutic infrastructure, growing post-acute care supervision, and rising demand in the emerging economies are expected to further propel the demand.

Companies Mentioned

  • Philips Healthcare
  • McKesson Corporation
  • Honeywell HomMed
  • Doctor on Demand
  • Teladoc
  • AMD Telemedicine
  • Aerotel Medical Systems Ltd.
  • Siemens
  • Polycom
  • Intel Corporation.
  • Cardio Net Inc.
  • IBM

Further key findings from the study suggest:

  • The products sub-segment registered largest revenue share in 2019 due to the increasing adoption of remote monitoring devices
  • Telemedicine found wide applications in dermatology, psychiatry, intensive care units, emergency care, ophthalmology, and radiology, out of which, teleradiology accounted for the majority of revenue in 2019
  • Web/mobile based delivery model is expected to witness significant growth in coming years due to the high adoption of smartphones and penetration of internet
  • The tele-homecare segment is anticipated to expand at a lucrative CAGR in coming years due to the increasing awareness regarding remote healthcare benefits among patients and introduction of advanced technologies to remotely monitor patient's health
  • The provider end-use segment held the dominant share of overall market in 2019. Government initiated healthcare programs across the world are anticipated to propel the adoption of telemedicine solutions by patients and providers in coming years

Key Topics Covered:

1 Methodology

2 Executive Summary

3 Industry Outlook

3.1 Market Segmentation

3.2 Market Lineage Outlook

3.2.1 Parent market analysis

3.2.2 Ancillary market Analysis

3.3 Market Variable Analysis

3.3.1 Market driver analysis

3.3.1.1 Lack of access to care & rising provider adoption of telemedicine

3.3.1.2 Rising consumer demand and increasing patient acceptance

3.3.1.3 Enhanced quality of care

3.3.2 Market restraint analysis

3.3.2.1 Lack of healthcare infrastructure and value evidence.

3.3.2.2 Reimbursement challenges and unclear regulations.

3.4 Penetration & Growth Prospect Mapping

3.5 Business Environment Analysis tools

4 Impact of Covid-19 in the Telemedicine Market

4.1. Current And Future Impact Analysis

4.1.1 Disease Prevalence Analysis (2019 Q4 - 2020)

4.1.1.1 COVID 19 patients

4.1.1.2 Others

4.2 Revised Reimbursement Guidelines

4.3 Opportunity Analysis

4.4 Market Entry Strategies

5 Telemedicine Market: Competitive Analysis

5.1. Innovators

5.2 Public Companies

6 Telemedicine Market: Components Segment Analysis

6.1 Telemedicine Market: Components Movement Analysis, 2019 & 2027

6.2 Product

6.3 Services

7 Telemedicine Market: Technology Segment Analysis

7.1 Telemedicine Market: Technology Movement Analysis, 2019 & 2027

7.2 Store and forward

7.2.1 Store and forward market, 2016 - 2027 (USD Million)

7.3 Real time

7.3.1 Real time market, 2016 - 2027 (USD Million)

7.4 Others

7.4.1 Others market, 2016 - 2027 (USD Million)

8 Telemedicine Market: Applications Segment Analysis

8.1 Telemedicine Market: Applications Movement Analysis, 2019 & 2027

8.2 Teleradiology

8.3 Telepsychiatry

8.4 Telepathology

8.5 Teledermatology

8.6 Telecardiology

8.7 Others

9 Telemedicine Market: Delivery Model Segment Analysis

9.1 Telemedicine Market: Delivery Model Movement Analysis, 2019 & 2027

9.2 Web/Mobile

9.3 Call Centers

10 Telemedicine Market: Type Segment Analysis

10.1 Telemedicine Market: Type Movement Analysis, 2019 & 2027

10.2 Tele-hospitals

10.3 Tele-home

11 Telemedicine Market: End Use Segment Analysis

11.1 Telemedicine Market: End Use Movement Analysis, 2019 & 2027

11.2 Providers

11.3 Payers

11.4 Patients

11.5 Others

12 Telemedicine Market: Regional Outlook

12.1 Telemedicine Market Share by Region, 2019 & 2027

12.2 North America

12.3 Europe

12.4 Asia Pacific

12.5 Latin America

12.6 MEA

13 Company Profiles

13.1 Strategic Framework

13.2 Company Profiles

For more information about this report visit https://www.researchandmarkets.com/r/qzl19o

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

U.S. Paid Social Forecast Report H1 2025: Spending Remains Resilient Despite Uncertainty and Changes Across Landscape - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "U.S. Paid Social Forecast Report H1 2025: Spending Remains Resilient Despite Uncertainty and Changes Across Landscape" report has been added to ResearchAndMarkets.com's offering. U.S. ad spend on social networks is expected to increase in 2025 despite tariffs and other challenges facing the sector. Investments in AI, social commerce, the continued rise of influencer marketing, and several other factors will fuel growth. How will ad spending across social networks c...

Enterprise Workforce Management Market Analysis Report 2025 Featuring Aspect, Assembled, Bright Pattern, Calabrio, NICE, and Verint Systems - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "2025 Workforce Management for the Enterprise" report has been added to ResearchAndMarkets.com's offering. This report provides an in-depth analysis of this mature yet evolving market whose continued projected growth is attributable to factors such as increasing adoption of cloud-based solutions, growing demand for remote work management, and the need for productivity improvements and operational efficiency across verticals. A reawakening and transforming sector It'...

$96.17 Bn In-vitro Diagnostics (IVD) Reagents Market - Global Outlook & Forecasts 2025-2030 Featuring Prominent Players - Abbott, Danaher, F. Hoffmann-La Roche, Siemens, and Thermo Fisher Scientific - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "In-vitro Diagnostics (IVD) Reagents Market - Global Outlook & Forecast 2025-2030" report has been added to ResearchAndMarkets.com's offering. The In-vitro Diagnostics (IVD) Reagents Market was valued at USD 77.56 Billion in 2024, and is projected to reach USD 96.17 Billion by 2030, rising at a CAGR of 3.65% The report considers the present scenario of the global IVD reagents market and its market dynamics for 2025-2030. It covers a detailed overview of several...
Back to Newsroom